Compare NTRA & PAYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRA | PAYX |
|---|---|---|
| Founded | 2003 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1B | 34.8B |
| IPO Year | 2015 | 1995 |
| Metric | NTRA | PAYX |
|---|---|---|
| Price | $212.07 | $100.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 16 |
| Target Price | ★ $259.07 | $111.67 |
| AVG Volume (30 Days) | 1.3M | ★ 2.7M |
| Earning Date | 05-07-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 4.59% |
| EPS Growth | ★ 0.65 | N/A |
| EPS | N/A | ★ 3.71 |
| Revenue | $210,939,000.00 | ★ $5,571,700,000.00 |
| Revenue This Year | $18.08 | $19.19 |
| Revenue Next Year | $19.65 | $5.50 |
| P/E Ratio | ★ N/A | $26.78 |
| Revenue Growth | N/A | ★ 5.56 |
| 52 Week Low | $131.81 | $85.45 |
| 52 Week High | $256.36 | $154.90 |
| Indicator | NTRA | PAYX |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 58.30 |
| Support Level | $186.96 | $87.59 |
| Resistance Level | $222.53 | $101.96 |
| Average True Range (ATR) | 10.51 | 2.71 |
| MACD | 0.34 | 0.14 |
| Stochastic Oscillator | 51.46 | 73.30 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Paychex is a cloud-based human capital management provider offering payroll, compliance, talent management, benefits administration, and retirement services. The firm also provides HR outsourcing services, including professional employer organization, or PEO, offerings, enabling clients to reduce HR overhead. Paychex primarily targets small and midsize businesses, although its acquisition of Paycor in 2025 signals the firm's aspirations to expand into the midmarket segment, serving firms with more than 100 employees. As of fiscal 2025, Paychex has approximately 800,000 clients and manages payroll for one in 11 workers in the United States.